Files
Download Full Text (623 KB)
Description
Attention Deficit Hyperactivity Disorder (ADHD) stands out as the most common childhood neurodevelopmental disorder, leading to functional challenges in various aspects of the daily lives of affected young individuals (Bul et al., 2016).
There is no current cure for ADHD, however effective treatments are available through medications. The FDA has authorized two types of medications for managing ADHD in children as young as 6 years old: stimulants, such as methylphenidate and amphetamine (e.g. Adderall), and non-stimulant options including Strattera, Intuniv, Kapvay, and Qelbree (U.S. Food and Drug Administration, 2023).
The choice of treatment is highly individualized to meet the specific needs of each patient and their family (CDC, 2023). It is noteworthy that 69.3% of children with ADHD receive medication as part of their treatment, while 30.7% do not (NSCH, 2011).
While extensive research has established the efficacy of medication-based approaches for ADHD management, there is insufficient research on non-pharmacological alternatives.
Department
Nursing
Publication Date
2023
Sponsorship/Conference/Institution
Dominican University of California
City
San Rafael, CA
Keywords
Attention Deficit Hyperactivity Disorder
Disciplines
Alternative and Complementary Medicine | Chemicals and Drugs | Educational Psychology | Nursing
Included in
Alternative and Complementary Medicine Commons, Chemicals and Drugs Commons, Educational Psychology Commons, Nursing Commons